Global PET Radiopharmaceuticals Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
ReportID: 649623
|
Published Date: Jun-22
|
No. of Pages: 250
|
Categories: Life Sciences
|
Format : 
The A2Z Market Research report on “Global PET Radiopharmaceuticals Market Report 2022 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029†offers strategic visions into the global PET Radiopharmaceuticals market along with the market size (Volume – Million Units and Revenue – US$ Billion) and estimates for the duration 2022 to 2029. The said research study covers in-depth analysis of multiple market segments based on type, application, and studies different topographies. The report is also inclusive of competitive profiling of the leading PET Radiopharmaceuticals product vendors, and their latest developments.
This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2022 to 2029. The study highlights current market trends for PET Radiopharmaceuticals and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global PET Radiopharmaceuticals market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the PET Radiopharmaceuticals market.
By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2029 for all the regions and sub-regions have also been provided in the report.
This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global PET Radiopharmaceuticals market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.
Some of the important players in PET Radiopharmaceuticals market are:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
Market segmentation by Type:
F-18
Ru-82
Others
Market segmentation by Application:
Oncology
Cardiology
Neurology
Others
This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2022 to 2029. The study highlights current market trends for PET Radiopharmaceuticals and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global PET Radiopharmaceuticals market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the PET Radiopharmaceuticals market.
By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2029 for all the regions and sub-regions have also been provided in the report.
This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global PET Radiopharmaceuticals market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.
Some of the important players in PET Radiopharmaceuticals market are:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
Market segmentation by Type:
F-18
Ru-82
Others
Market segmentation by Application:
Oncology
Cardiology
Neurology
Others
Global PET Radiopharmaceuticals Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
Chapter 1 PET Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of PET Radiopharmaceuticals
1.2 PET Radiopharmaceuticals Market Segmentation by Type
1.2.1 Global Production Market Share of PET Radiopharmaceuticals by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 PET Radiopharmaceuticals Market Segmentation by Application
1.3.1 PET Radiopharmaceuticals Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 PET Radiopharmaceuticals Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of PET Radiopharmaceuticals (2014-2029)
Chapter 2 Global Economic Impact on PET Radiopharmaceuticals Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global PET Radiopharmaceuticals Market Competition by Manufacturers
3.1 Global PET Radiopharmaceuticals Production and Share by Manufacturers (2020 and 2022)
3.2 Global PET Radiopharmaceuticals Revenue and Share by Manufacturers (2020 and 2022)
3.3 Global PET Radiopharmaceuticals Average Price by Manufacturers (2020 and 2022)
3.4 Manufacturers PET Radiopharmaceuticals Manufacturing Base Distribution, Production Area and Product Type
3.5 PET Radiopharmaceuticals Market Competitive Situation and Trends
3.5.1 PET Radiopharmaceuticals Market Concentration Rate
3.5.2 PET Radiopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global PET Radiopharmaceuticals Production, Revenue (Value) by Region (2014-2022)
4.1 Global PET Radiopharmaceuticals Production by Region (2014-2022)
4.2 Global PET Radiopharmaceuticals Production Market Share by Region (2014-2022)
4.3 Global PET Radiopharmaceuticals Revenue (Value) and Market Share by Region (2014-2022)
4.4 Global PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
4.5 North America PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
4.6 Europe PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
4.7 China PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
4.8 Japan PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
4.9 Southeast Asia PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
4.10 India PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
Chapter 5 Global PET Radiopharmaceuticals Supply (Production), Consumption, Export, Import by Regions (2014-2022)
5.1 Global PET Radiopharmaceuticals Consumption by Regions (2014-2022)
5.2 North America PET Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2022)
5.3 Europe PET Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2022)
5.4 China PET Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2022)
5.5 Japan PET Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2022)
5.6 Southeast Asia PET Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2022)
5.7 India PET Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2022)
Chapter 6 Global PET Radiopharmaceuticals Production, Revenue (Value), Price Trend by Type
6.1 Global PET Radiopharmaceuticals Production and Market Share by Type (2014-2022)
6.2 Global PET Radiopharmaceuticals Revenue and Market Share by Type (2014-2022)
6.3 Global PET Radiopharmaceuticals Price by Type (2014-2022)
6.4 Global PET Radiopharmaceuticals Production Growth by Type (2014-2022)
Chapter 7 Global PET Radiopharmaceuticals Market Analysis by Application
7.1 Global PET Radiopharmaceuticals Consumption and Market Share by Application (2014-2022)
7.2 Global PET Radiopharmaceuticals Consumption Growth Rate by Application (2014-2022)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 PET Radiopharmaceuticals Manufacturing Cost Analysis
8.1 PET Radiopharmaceuticals Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of PET Radiopharmaceuticals
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 PET Radiopharmaceuticals Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of PET Radiopharmaceuticals Major Manufacturers in 2020
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global PET Radiopharmaceuticals Market Forecast (2022-2029)
12.1 Global PET Radiopharmaceuticals Production, Revenue Forecast (2022-2029)
12.2 Global PET Radiopharmaceuticals Production, Consumption Forecast by Regions (2022-2029)
12.3 Global PET Radiopharmaceuticals Production Forecast by Type (2022-2029)
12.4 Global PET Radiopharmaceuticals Consumption Forecast by Application (2022-2029)
12.5 PET Radiopharmaceuticals Price Forecast (2022-2029)
Chapter 13 Appendix
Chapter 1 PET Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of PET Radiopharmaceuticals
1.2 PET Radiopharmaceuticals Market Segmentation by Type
1.2.1 Global Production Market Share of PET Radiopharmaceuticals by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 PET Radiopharmaceuticals Market Segmentation by Application
1.3.1 PET Radiopharmaceuticals Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 PET Radiopharmaceuticals Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of PET Radiopharmaceuticals (2014-2029)
Chapter 2 Global Economic Impact on PET Radiopharmaceuticals Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global PET Radiopharmaceuticals Market Competition by Manufacturers
3.1 Global PET Radiopharmaceuticals Production and Share by Manufacturers (2020 and 2022)
3.2 Global PET Radiopharmaceuticals Revenue and Share by Manufacturers (2020 and 2022)
3.3 Global PET Radiopharmaceuticals Average Price by Manufacturers (2020 and 2022)
3.4 Manufacturers PET Radiopharmaceuticals Manufacturing Base Distribution, Production Area and Product Type
3.5 PET Radiopharmaceuticals Market Competitive Situation and Trends
3.5.1 PET Radiopharmaceuticals Market Concentration Rate
3.5.2 PET Radiopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global PET Radiopharmaceuticals Production, Revenue (Value) by Region (2014-2022)
4.1 Global PET Radiopharmaceuticals Production by Region (2014-2022)
4.2 Global PET Radiopharmaceuticals Production Market Share by Region (2014-2022)
4.3 Global PET Radiopharmaceuticals Revenue (Value) and Market Share by Region (2014-2022)
4.4 Global PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
4.5 North America PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
4.6 Europe PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
4.7 China PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
4.8 Japan PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
4.9 Southeast Asia PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
4.10 India PET Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2022)
Chapter 5 Global PET Radiopharmaceuticals Supply (Production), Consumption, Export, Import by Regions (2014-2022)
5.1 Global PET Radiopharmaceuticals Consumption by Regions (2014-2022)
5.2 North America PET Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2022)
5.3 Europe PET Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2022)
5.4 China PET Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2022)
5.5 Japan PET Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2022)
5.6 Southeast Asia PET Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2022)
5.7 India PET Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2022)
Chapter 6 Global PET Radiopharmaceuticals Production, Revenue (Value), Price Trend by Type
6.1 Global PET Radiopharmaceuticals Production and Market Share by Type (2014-2022)
6.2 Global PET Radiopharmaceuticals Revenue and Market Share by Type (2014-2022)
6.3 Global PET Radiopharmaceuticals Price by Type (2014-2022)
6.4 Global PET Radiopharmaceuticals Production Growth by Type (2014-2022)
Chapter 7 Global PET Radiopharmaceuticals Market Analysis by Application
7.1 Global PET Radiopharmaceuticals Consumption and Market Share by Application (2014-2022)
7.2 Global PET Radiopharmaceuticals Consumption Growth Rate by Application (2014-2022)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 PET Radiopharmaceuticals Manufacturing Cost Analysis
8.1 PET Radiopharmaceuticals Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of PET Radiopharmaceuticals
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 PET Radiopharmaceuticals Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of PET Radiopharmaceuticals Major Manufacturers in 2020
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global PET Radiopharmaceuticals Market Forecast (2022-2029)
12.1 Global PET Radiopharmaceuticals Production, Revenue Forecast (2022-2029)
12.2 Global PET Radiopharmaceuticals Production, Consumption Forecast by Regions (2022-2029)
12.3 Global PET Radiopharmaceuticals Production Forecast by Type (2022-2029)
12.4 Global PET Radiopharmaceuticals Consumption Forecast by Application (2022-2029)
12.5 PET Radiopharmaceuticals Price Forecast (2022-2029)
Chapter 13 Appendix
Published On:Jun-22
Base Year:
Historical Data:
No of Pages:250
Price
Global PET Radiopharmaceuticals Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
